Vident Advisory, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1744347 Alpharetta, GA

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,866,104

+$2,201,270 QoQ

Shares Held

7,804

+126.3% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#395

of 1,329 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

Vident Advisory, LLC holds $52,891,507 across 43 Biotechnology names. REGN ranks #4 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	148,975	$8,105,728
2	JAZZ	Jazz Pharmaceuticals plc	28,409	$6,845,716
3	VRTX	Vertex Pharmaceuticals Inc / Ma	12,522	$6,220,051
4	REGN	Regeneron Pharmaceuticals, Inc. This page	7,804	$4,866,104
5	RVMD	Revolution Medicines, Inc.	13,776	$2,579,967
6	LGND	Ligand Pharmaceuticals Inc	6,151	$1,944,268
7	ALNY	Alnylam Pharmaceuticals, Inc.	5,518	$1,661,083
8	CYTK	Cytokinetics Inc	15,898	$1,354,349

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,866,104	7,804	+126.3%	Shares	Defined	2026-08-12
2026-03-31	$2,664,834	3,449	+29.3%	Shares	Defined	2026-05-15
2025-12-31	$2,059,347	2,668	-0.6%	Shares	Sole	2026-02-18
2025-09-30	$1,509,693	2,685	+9.6%	Shares	Defined	2025-11-14
2025-06-30	$1,285,725	2,449	-6.6%	Shares	Sole	2025-08-14
2025-03-31	$1,662,951	2,622	-43.9%	Shares	Sole	2025-05-15
2024-12-31	$3,331,565	4,677	+228.7%	Shares	Defined	2025-02-14
2024-09-30	$1,495,914	1,423	-75.8%	Shares	Sole	2024-11-14
2024-06-30	$6,171,647	5,872	-76.3%	Shares	Sole	2024-08-14
2024-03-31	$23,804,300	24,732	+24.5%	Shares	Defined	2024-05-14
2023-12-31	$17,453,376	19,872	-9.1%	Shares	Sole	2024-02-14
2023-09-30	$17,991,549	21,862	—	Shares	Sole	2024-02-21
No filing history on record for this holder in this stock.